Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares shot up 1.7% on Wednesday. The company traded as high as $1.24 and last traded at $1.20. Approximately 2,034,234 shares changed hands during trading, an increase of 2,932% from the average session volume of 67,097 shares. The stock had previously closed at $1.18.
Cardiol Therapeutics Stock Performance
The company’s 50 day simple moving average is $1.75 and its 200-day simple moving average is $1.41.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a Canadian clinical-stage biotechnology company focused on developing anti-inflammatory therapies for diseases affecting the heart. The company’s research is centered on conditions in which inflammation can contribute to cardiac injury and impaired heart function, including myocarditis and pericarditis.
Cardiol’s lead investigational product, CardiolRx, is a pharmaceutical-grade oral cannabidiol formulation being evaluated as a potential treatment for acute myocarditis and recurrent pericarditis.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
